Using this approach, we revealed that adipocyte-specific IFNAR expression contributes to obesity-associated glucose dysmetabolism (in agreement with total body IFNAR−/− deletion and reciprocal BMT), but was not sufficient by itself to alter hepatocellular damage (Fig. 6). The gene discussed is IFNAR1; the disease is obesity due to melanocortin 4 receptor deficiency.